摘要
谷氨酸能通路的功能异常可能是精神分裂症的病理基础。在疾病病理学中氧化应激的证据也被报道。N-乙酰天冬氨酸既在新陈代谢上与级联有关,也可能是探索谷氨酸能通路和氧化应激互连的一个关键标志物。几项研究已经报道,在一些健康受试者的大脑区域,通过使用氢核磁共振谱([1H]MRS)的测定,NAA和Glx的水平之间存在正相关(谷氨酸和谷氨酰胺的总和)。有趣的是,一个研究小组最近报道了精神分裂症患者的海马回中NAA和Glx之间的解耦关系。在此,我们报告了用氢核磁共振谱测定的NAA和Glx水平,相对肌酸的水平(Cr)作为内标。对25例精神分裂症患者和17个匹配的健康对照组的背外侧前额叶皮层(DLPFC)和前扣带皮层(ACC)进行了研究。在进行了年龄和吸烟状况影响的校正,和多重比较校正后,健康对照组的背外侧前额叶皮层中NAA/Cr和Glx/Cr值呈极显著的正相性(r = 0.627,P = 0.627)。然而,在精神分裂症患者中NAA/Cr和Glx/Cr值没有观察到正相关性,即使校正了这两个变量(r = -0.330,P = -0.330)。两组的前扣带皮层中NAA/Cr和Glx/Cr值均未观察到正相关性。背外侧前额叶皮层中N-乙酰天冬氨酸和谷氨酸盐的解耦可能反映了精神分裂症病理学中谷氨酸能通路和氧化应激之间的关联,其可能是疾病的生物标志物。
关键词: 前扣带皮层(ACC),背外侧前额叶皮层(DLPFC),谷氨酸盐,N-乙酰天冬氨酸(NAA),线粒体,氧化应激,氢核磁共振谱([1H]MRS)
Current Molecular Medicine
Title:Decoupling of N-Acetyl-Aspartate and Glutamate Within the Dorsolateral Prefrontal Cortex in Schizophrenia
Volume: 15 Issue: 2
Author(s): J.M. Coughlin, T. Tanaka, A. Marsman, H. Wang, S. Bonekamp, P.K. Kim, C. Higgs, M. Varvaris and R.A.E. Edden, M. Pomper, D. Schretlen, P.B. Barker and A. Sawa
Affiliation:
关键词: 前扣带皮层(ACC),背外侧前额叶皮层(DLPFC),谷氨酸盐,N-乙酰天冬氨酸(NAA),线粒体,氧化应激,氢核磁共振谱([1H]MRS)
摘要: Aberrant function of glutamatergic pathways is likely to underlie the pathology of schizophrenia. Evidence of oxidative stress in the disease pathology has also been reported. N-Acetylaspartate (NAA) is metabolically linked to both cascades and may be a key marker in exploring the interconnection of glutamatergic pathways and oxidative stress. Several studies have reported positive correlation between the levels of NAA and Glx (the sum of glutamate and glutamine) in several brain regions in healthy subjects, by using proton magnetic resonance spectroscopy ([1H]MRS). Interestingly, one research group recently reported decoupling of the relationship between NAA and Glx in the hippocampus of patients with schizophrenia. Here we report levels of NAA and Glx measured using [1H]MRS, relative to the level of creatine (Cr) as an internal control. The dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) in 25 patients with schizophrenia and 17 matched healthy controls were studied. In DLPFC, NAA/Cr and Glx/Cr were significantly positively correlated in healthy controls after correction for the effect of age and smoking status and after correction for multiple comparisons (r= 0.627, P= 0.017). However, in patients with schizophrenia, the positive correlation between NAA/Cr and Glx/Cr was not observed even after correcting for these two variables (r= -0.330, P= 0.124). Positive correlation between NAA/Cr and Glx/Cr was not observed in the ACC in both groups. Decoupling of NAA and Glx in the DLPFC may reflect the interconnection of glutamatergic pathways and oxidative stress in the pathology of schizophrenia, and may possibly be a biomarker of the disease.
Export Options
About this article
Cite this article as:
J.M. Coughlin, T. Tanaka, A. Marsman, H. Wang, S. Bonekamp, P.K. Kim, C. Higgs, M. Varvaris and R.A.E. Edden, M. Pomper, D. Schretlen, P.B. Barker and A. Sawa , Decoupling of N-Acetyl-Aspartate and Glutamate Within the Dorsolateral Prefrontal Cortex in Schizophrenia, Current Molecular Medicine 2015; 15 (2) . https://dx.doi.org/10.2174/1566524015666150303104811
DOI https://dx.doi.org/10.2174/1566524015666150303104811 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Induction of Myocardial Fibrosis and Hypertrophy by Natriuretic Peptides
Vascular Disease Prevention (Discontinued) Targeting New Pharmacological Approaches for Alzheimer’s Disease: Potential for Statins and Phosphodiesterase Inhibitors
CNS & Neurological Disorders - Drug Targets Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Current Stem Cell Research & Therapy Editorial (Current and Emerging Pharmacological Therapies of Ischaemic Stroke)
CNS & Neurological Disorders - Drug Targets Delivery Systems of Opioid Analgesics for Pain Relief: A Review
Current Pharmaceutical Design Subject Index Volume 2
Current Pediatric Reviews Nasal Delivery of Antioxidants by Cholesterol-incorporated Liposomes Extends the Neuroprotective Time Window in Cerebral Ischemia
Current Pharmaceutical Design Medico-Legal Issues with CTG Interpretation
Current Women`s Health Reviews Implications of the Molecular Basis of Prostacyclin Biosynthesis and Signaling in Pharmaceutical Designs
Current Pharmaceutical Design Modulating Mitochondria-Mediated Apoptotic Cell Death through Targeting of Bcl-2 Family Proteins
Recent Patents on DNA & Gene Sequences Inhibiting the Enzymes of the Endothelin and Renin-Angiotensin Systems in Cancer
Current Enzyme Inhibition Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design Recent Advances of 1,2,4-triazolo[3,4-α]pyridines: Synthesis and Bioactivities
Current Organic Chemistry Vascular Patency: A Biomarker and Clinical Target Quantified with High Resolution MRI and Novel Cellular Pathways
Current Neurovascular Research Recent Advances in the Imaging of Programmed Cell Death
Current Pharmaceutical Design Tachykinins and Tachykinin Receptors: Structure and Activity Relationships
Current Medicinal Chemistry Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
Current Pharmacogenomics and Personalized Medicine Aquaporin and Vascular Diseases
Current Neuropharmacology Positive Airway Pressure in Sleep Disordered Breathing
Current Respiratory Medicine Reviews